Kanamycin description: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
 
Line 10: Line 10:
|}
|}


Kanamycin Injection, USP, sterile solution for parenteral administration, contains respectively; kanamycin sulfate equivalent to 500 mg and 1g kanamycin; sodium bisulfite, an antioxidant, 0.66% and 0.45%; and sodium citrate, 2.2% and 2.2% with pH of each dosage form adjusted to 4.5 with sulfuric acid.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = KANAMYCIN (KANAMYCIN A SULFATE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4865638-1259-4eef-a73c-fe919af6e850 | publisher =  | date =  | accessdate = }}</ref>
Kanamycin Injection, USP, sterile solution for parenteral administration, contains respectively; kanamycin sulfate equivalent to 500 mg and 1g kanamycin; sodium bisulfite, an [[antioxidant]], 0.66% and 0.45%; and sodium [[citrate]], 2.2% and 2.2% with pH of each dosage form adjusted to 4.5 with sulfuric acid.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = KANAMYCIN (KANAMYCIN A SULFATE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4865638-1259-4eef-a73c-fe919af6e850 | publisher =  | date =  | accessdate = }}</ref>


==References==
==References==

Latest revision as of 16:49, 7 January 2014

Kanamycin
KANAMYCIN® Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Description

Kanamycin sulfate is an aminoglycoside antibiotic produced by Streptomyces kanamyceticus. It is D-Streptamine, 0-3-amino-3-deoxy-α-D-glucopyranosyl - (1→6)-0- [6-amino-6-deoxy-α-D-glucopyranosyl - (1→4)]-2-deoxy, sulfate 1:1 (salt). It consists of two amino sugars glycosidically linked to deoxystreptamine.

Kanamycin Injection, USP, sterile solution for parenteral administration, contains respectively; kanamycin sulfate equivalent to 500 mg and 1g kanamycin; sodium bisulfite, an antioxidant, 0.66% and 0.45%; and sodium citrate, 2.2% and 2.2% with pH of each dosage form adjusted to 4.5 with sulfuric acid.[1]

References

  1. "KANAMYCIN (KANAMYCIN A SULFATE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]".

Adapted from the FDA Package Insert.